Phase I/II Study of Oral S-1 Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer
Condition(s):Pancreatic CancerLast Updated:November 1, 2007Suspended
Hide Studies Not Open or Pending
Condition(s):Pancreatic CancerLast Updated:November 1, 2007Suspended
Condition(s):Pancreatic CancerLast Updated:November 21, 2017Completed
Condition(s):Recurrent Pancreatic Carcinoma; Stage IV Pancreatic CancerLast Updated:August 7, 2017Completed
Condition(s):Pancreatic Neoplasm; Gastric NeoplasmLast Updated:November 13, 2018Completed
Condition(s):Locally Advanced Pancreatic CancerLast Updated:May 17, 2018Withdrawn
Condition(s):Pancreatic NeoplasmsLast Updated:May 4, 2022Completed
Condition(s):Pancreatic TumorsLast Updated:June 4, 2015Withdrawn
Condition(s):Pancreatic Cancer; Patient Reported Outcome Measures; Quality of Life; Pancreatectomy; Nutritional Status; Recovery of FunctionLast Updated:January 18, 2024Active, not recruiting
Condition(s):Pancreatic Cancer; Chronic Pancreatitis; Type II Diabetes; Pancreatic Cysts; Healthy ControlLast Updated:November 8, 2017Completed
Condition(s):Pancreatic CancerLast Updated:December 19, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.